New York State Teachers Retirement System (NYSTRS)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,300
Closed -$497K 1663
2023
Q3
$497K Hold
4,300
﹤0.01% 1411
2023
Q2
$442K Hold
4,300
﹤0.01% 1435
2023
Q1
$469K Hold
4,300
﹤0.01% 1421
2022
Q4
$489K Hold
4,300
﹤0.01% 1415
2022
Q3
$266K Buy
4,300
+3,700
+617% +$259K ﹤0.01% 1485
2022
Q2
$48K Sell
600
-2,700
-82% -$256K ﹤0.01% 1580
2022
Q1
$347K Hold
3,300
﹤0.01% 1475
2021
Q4
$356K Buy
+3,300
New +$360K ﹤0.01% 1481
2020
Q2
Sell
-2,300
Closed -$68K 1675
2020
Q1
$68K Hold
2,300
﹤0.01% 1529
2019
Q4
$83K Hold
2,300
﹤0.01% 1594
2019
Q3
$63K Hold
2,300
﹤0.01% 1556
2019
Q2
$55K Buy
+2,300
New +$58.3K ﹤0.01% 1563

Other funds holding HZNP

New York State Teachers Retirement System (NYSTRS)'s HZNP Position: Q4 2023 in Review

New York State Teachers Retirement System (NYSTRS) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 4,300 shares — an estimated $497K sold.

New York State Teachers Retirement System (NYSTRS) first reported a position in HZNP in Q2 2019 and held it in 12 quarters. The position peaked at $497K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • New York State Teachers Retirement System (NYSTRS) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • New York State Teachers Retirement System (NYSTRS) sold 4,300 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $497K.
  • New York State Teachers Retirement System (NYSTRS) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2019 and held it in 12 quarters.
  • New York State Teachers Retirement System (NYSTRS)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $497K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on New York State Teachers Retirement System (NYSTRS)'s 13F filing for Q4 2023, filed 24 Jan 2024.